11C-MET
Showing 1 - 25 of >10,000
Posterior Brain Fossa Tumors in Children Trial in Bron (11C-MET PET/MRI)
Completed
- Posterior Brain Fossa Tumors in Children
- 11C-MET PET/MRI
-
Bron, FranceHospices Civils de Lyon - Groupement Hospitalier Est - Hôpital F
Nov 29, 2021
Inflammation in Alzheimer's Disease and Related Dementias Using
Recruiting
- Alzheimer Disease
-
Saint Louis, MissouriWashington University School of Medicine
Nov 9, 2023
Lung Non-Small Cell Carcinoma Trial (Amivantamab, Biospecimen Collection, Computed Tomography)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Amivantamab
- +3 more
- (no location specified)
Oct 30, 2023
Tauopathies Trial in Philadelphia (drug, diagnostic test, behavioral)
Active, not recruiting
- Tauopathies
- 11C-HY-2-15 PET
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Sep 6, 2023
Ketoses, Metabolic Trial (Observational heart and kidney on siemens TEP scan)
Completed
- Ketoses, Metabolic
- Observational heart and kidney on siemens TEP scan
-
Sherbrooke, Quebec, CanadaResearch Center on Aging
Jan 16, 2023
ALS Trial ([11C]CPPC PET ligand)
Not yet recruiting
- ALS
- [11C]CPPC PET ligand
- (no location specified)
Jan 9, 2023
Solid Tumor Trial in Bengbu (SPH 3348)
Recruiting
- Solid Tumor
- SPH 3348
-
Bengbu, Anhui, ChinaThe First Affliated Hospital of Bengbu Medical College
Jul 25, 2022
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)
Recruiting
- Glioblastoma Multiforme
- 11C-Methionine PET/CT
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Nov 3, 2022
PreDiabetes Trial in Mexico City (Life Style Intervention + Metformin, Life Style Intervention)
Recruiting
- PreDiabetes
- Life Style Intervention + Metformin
- Life Style Intervention
-
Mexico City, MexicoInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Aug 10, 2023
Melanoma Trial in Chapel Hill, Raleigh (FDG PET/CT scan, C11-AMT PET scan, Pembrolizumab)
Active, not recruiting
- Melanoma
- FDG PET/CT scan
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Jan 10, 2023
11C-para-aminobenzoic Acid
Recruiting
- Renal Excretion
- +3 more
- 11C-para-aminobenzoic acid PET/CT
- Probenecid
-
Baltimore, MarylandJohns Hopkins Medical Institutions
Jan 30, 2023
NSCLC Trial (Telisotuzumab Vedotin, Osimertinib, Cisplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Telisotuzumab Vedotin
- +4 more
- (no location specified)
Oct 17, 2023
Novel FLUorescENt C-mEt Tracer in Penile and Tongue
Completed
- Head and Neck Cancer
- Penile Cancer
-
Amsterdam, Noord-Holland, NetherlandsThe Netherlands Cancer Institute / Antoni van Leeuwenhoek
Oct 18, 2022
Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)
Not yet recruiting
- Crohn's Disease
-
Stockholm, SwedenResearch Site
Sep 22, 2023
Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.
Not yet recruiting
- Huntington Disease
- [11C]UCB-J
- [18F]SynVest-1
-
Leuven, BelgiumUZ Leuven
Nov 2, 2022
Diabetes, Type 2, Heart Failure, Healthy Trial in Aarhus N (3-[11C]-OHB)
Recruiting
- Diabetes Mellitus, Type 2
- +2 more
- 3-[11C]-OHB
-
Aarhus N, Jutland, DenmarkAarhus University Hospital
Nov 1, 2022
Primary Aldosteronism Due to Aldosterone Producing Adenoma, Primary Aldosteronism, Adrenal Tumors Trial in Singapore
Recruiting
- Primary Aldosteronism Due to Aldosterone Producing Adenoma
- +2 more
- 11C-Metomidate PET/CT imaging at Clinical Imaging Research Centre
-
Singapore, Singapore
- +6 more
Oct 26, 2023
Cocaine Use Disorder Trial in Pittsburgh (Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan)
Recruiting
- Cocaine Use Disorder
- Baseline [C-11]NPA PET Scan
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of PIttsburgh
Jun 27, 2022
Advanced Solid Tumors Trial in Goyang-si, Seoul (ABN401)
Not yet recruiting
- Advanced Solid Tumors
-
Goyang-si, Gyeonggi-Do, Korea, Republic of
- +2 more
Sep 13, 2022
MDD Trial in Shanghai (Toludesvenlafaxine HCl sustained-release tablets)
Not yet recruiting
- Major Depressive Disorder
- Toludesvenlafaxine hydrochloride sustained-release tablets
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
Sep 7, 2023
CNS Tumor, Head and Neck Tumors Trial in Memphis (L-(11C) methionine)
Available
- Central Nervous System Tumor
- Head and Neck Neoplasms
- L-(11C) methionine
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 19, 2022